Market Currents
Dendreon (DNDN -7.2%) nears its 52-week low after BofA downgrades shares to Underperform, and...
-
Wednesday, July 11, 2012, 1:39 PM ETDendreon (DNDN -7.2%) nears its 52-week low after BofA downgrades shares to Underperform, and lowers its PT to $6 from $13. The firm expects Provenge sales to fall short of expectations for the next several quarters, keeping the business in the red, and that such a weak demand environment will limit the valuation an acquirer is willing to pay.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 2 comments:
aggressive marketing should make this company very profitable
Charlie